Drreddys Laboratories reported INR290.97B in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Ani Pharmaceuticals ANIP:US USD 739.11M 12.22M
Aurora Cannabis Inc ACB:CN CAD 1.17B 85.57M
Bayer BAYN:GR EUR 131.01B 2.22B
Canopy Growth Corp WEED:CN CAD 3.4B 115.26M
Catalent CTLT:US USD 10.2B 302M
Corcept Therapeutics CORT:US USD 533.26M 36.89M
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
GlaxoSmithKline GSK:LN GBP 60.31B 28.73B
Hikma Pharmaceutical HIK:LN USD 4.75B 375M
Horizon Pharma HZNP:US USD 9.03B 174.39M
Lannett LCI:US USD 467.3M 17.14M
Lonza Group LONN:SW CHF 17.36B 613M
Novartis NOVN:VX USD 118.46B 4.45B
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Phibro Animal Health PAHC:US USD 948.38M 16.68M
Prestige Brands PBH:US USD 3.68B 3.72M
Richter Gedeon RICHT:HB HUF 1.39T 97.98B
Supernus Pharmaceuticals SUPN:US USD 1.69B 1.84M
Teva Pharmaceutical TEVA:IT USD 44.25B 1.68B